The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
The growth and potential of human antiviral monoclonal antibody therapeutics
Open accessAbstract
Monoclonal antibodies (mAbs) have long provided powerful research tools for virologists to understand the mechanisms of virus entry into host cells and of antiviral immunity. Even so, commercial development of human (or humanized) mAbs for the prophylaxis, preemptive and acute treatment of viral infections has been slow. This is surprising, as new antibody discovery tools have increased the speed and precision with which potent neutralizing human antiviral mAbs can be identified. As longstanding barriers to antiviral mAb development, such as antigenic variability of circulating viral strains and the ability of viruses to undergo neutralization escape, are being overcome, deeper insight into the mechanisms of mAb action and engineering of effector functions are also improving the efficacy of antiviral mAbs. These successes, in both industrial and academic laboratories, coupled with ongoing changes in the biomedical and regulatory environments, herald an era when the commercial development of human antiviral mAb therapies will likely surge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin
Skehel, J. J., & Wiley, D. C. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.531 · Cited by 2,706
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
Potent antibody therapeutics by design
Carter, P. J. (2006) · Nature Reviews Immunology · doi:10.1038/nri1837 · Cited by 1,099
Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding
Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,037
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Natural regulatory T cells in infectious disease
Belkaid, Y., & Rouse, B. T. (2005) · Nature Immunology · doi:10.1038/ni1181 · Cited by 1,035
A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., & Katinger, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6642-6647.1993 · Cited by 1,004
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
Selecting and screening recombinant antibody libraries
Hoogenboom, H. R. (2005) · Nature Biotechnology · doi:10.1038/nbt1126 · Cited by 973
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889 · cited 1×
“Likewise, recent studies have demonstrated that the pathway PD-1/PD-1L, which are members of the B7-CD28 family of inhibitory immunoregulatory molecules, plays a major role in regulating CD8 + T-cell exhaustion during chronic lymphocytic choriomeningitis virus (LCMV) and HIV-1 infection [44] [45] [46] [47] [48] .”
ResultEngineered antibody Fc variants with enhanced effector function
Lazar, G. A., Dang, W., Karki, S., Vafa, O., Peng, J. S., Hyun, L., Chan, C., Chung, H. S., Eivazi, A., Yoder, S. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508123103 · Cited by 803
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
How Viruses Enter Animal Cells
Smith, A. E., & Helenius, A. (2004) · Science · doi:10.1126/science.1094823 · Cited by 734
Regulatory T cells: friend or foe in immunity to infection?
Mills, K. H. G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1485 · Cited by 702
Virus entry: molecular mechanisms and biomedical applications
Dimitrov, D. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro817 · Cited by 701
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
Parren, P. W. H. I., Marx, P. A., Hessell, A. J., Luckay, A., Harouse, J., Cheng-Mayer, C., Moore, J. P., & Burton, D. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8340-8347.2001 · Cited by 662
Antibodies, viruses and vaccines
Burton, D. R. (2002) · Nature Reviews Immunology · doi:10.1038/nri891 · Cited by 637
Meta-Analysis: Convalescent Blood Products for Spanish Influenza Pneumonia: A Future H5N1 Treatment?
Luke, T. C., Kilbane, E. M., Jackson, J. L., & Hoffman, S. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00139 · Cited by 636
ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 612
Yamane‐Ohnuki, N., Kinoshita, S., Inoue‐Urakubo, M., Kusunoki, M., Iida, S., Nakano, R., Wakitani, M., Niwa, R., Sakurada, M., Uchida, K., et al. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20151 · Cited by 572
Sui, J., Li, W., Murakami, A., Tamin, A., Matthews, L. J., Wong, S. K., Moore, M. J., Tallarico, A. S. C., Olurinde, M., Choe, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307140101 · Cited by 550
Self-citationTherapeutic antibodies for human diseases at the dawn of the twenty-first century
Brekke, O. H., & Sandlie, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd984 · Cited by 550
Frame, J. D., Baldwin, J. M., Gocke, D. J., & Troup, J. M. (1970) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1970.19.670 · Cited by 536
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L.-A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 531
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Kaufmann, D. E., Kavanagh, D. G., Pereyra, F., Zaunders, J. J., Mackey, E. W., Miura, T., Palmer, S., Brockman, M., Rathod, A., Piechocka-Trocha, A., et al. (2007) · Nature Immunology · doi:10.1038/ni1515 · Cited by 524
CCR5 deficiency increases risk of symptomatic West Nile virus infection
Glass, W. G., McDermott, D. H., Lim, J. K., Lekhong, S., Yu, S. F., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051970 · Cited by 519
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
Oliphant, T., Engle, M., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A., Chung, K. M., et al. (2005) · Nature Medicine · doi:10.1038/nm1240 · Cited by 514
Trkola, A., Kuster, H., Rusert, P., Joos, B., Fischer, M., Leemann, C., Manrique, A., Huber, M., Rehr, M., Oxenius, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1244 · Cited by 502
Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., et al. (2003) · Nature Medicine · doi:10.1038/nm833 · Cited by 460
In Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
Halstead, S. B. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.527 · Cited by 438
Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses
Radoshitzky, S. R., Abraham, J., Spiropoulou, C. F., Kuhn, J. H., Nguyen, D., Li, W., Nagel, J., Schmidt, P. J., Nunberg, J. H., Andrews, N. C., et al. (2007) · Nature · doi:10.1038/nature05539 · Cited by 438
Optimization of humanized IgGs in glycoengineered Pichia pastoris
Li, H., Sethuraman, N., Stadheim, T. A., Zha, D., Prinz, B., Ballew, N., Bobrowicz, P., Choi, B.-K., Cook, W. J., Cukan, M., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1178 · Cited by 428
Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients
Mupapa, K., Massamba, M., Kibadi, K., Kuvula, K., Bwaka, A., Kipasa, M., Colebunders, R., Muyembe‐Tamfum, J. J., & the International Scientific and Technical Committee (1999) · The Journal of Infectious Diseases · doi:10.1086/514298 · Cited by 420
Treatment with Convalescent Plasma for Influenza A (H5N1) Infection
Zhou, B., Zhong, N., & Guan, Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070359 · Cited by 406
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
Freeman, G. J., Wherry, E. J., Ahmed, R., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061800 · Cited by 399
Glass, W. G., Lim, J. K., Cholera, R., Pletnev, A. G., Gao, J.-L., & Murphy, P. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042530 · Cited by 391
Passive immunity in prevention and treatment of infectious diseases
Keller, M. A., & Stiehm, E. R. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.602 · Cited by 388
The Many Mechanisms of Viral Membrane Fusion Proteins
Earp, L. J., Delos, S. E., Park, H. E., & White, J. M. (2004) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26764-6_2 · Cited by 379
Wu, H., Pfarr, D. S., Johnson, S., Brewah, Y. A., Woods, R. M., Patel, N. K., White, W. I., Young, J. F., & Kiener, P. A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.024 · Cited by 373
Goncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364
Maiztegui, J., Fernandez, N., & De Damilano, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92335-3 · Cited by 332
Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
Casadevall, A., & Scharff, M. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.150 · Cited by 318
Antiviral antibody responses: the two extremes of a wide spectrum
Hangartner, L., Zinkernagel, R. M., & Hengartner, H. (2006) · Nature Reviews Immunology · doi:10.1038/nri1783 · Cited by 314
The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection
Pierson, T. C., Xu, Q., Nelson, S., Oliphant, T., Nybakken, G. E., Fremont, D. H., & Diamond, M. S. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.03.002 · Cited by 308
Monoclonal Antibody Mapping of the Envelope Glycoprotein of the Dengue 2 Virus, Jamaica
Roehrig, J. T., Bolin, R. A., & Kelly, R. G. (1998) · Virology · doi:10.1006/viro.1998.9200 · Cited by 307
Palivizumab Prophylaxis, Respiratory Syncytial Virus, and Subsequent Recurrent Wheezing
Simoes, E. A. F., Groothuis, J. R., Carbonell-Estrany, X., Rieger, C. H. L., Mitchell, I., Fredrick, L. M., & Kimpen, J. L. L. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.02.032 · Cited by 305
Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection
Maruyama, T., Rodriguez, L. L., Jahrling, P. B., Sanchez, A., Khan, A. S., Nichol, S. T., Peters, C. J., Parren, P. W. H. I., & Burton, D. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.6024-6030.1999 · Cited by 293
Occupancy and mechanism in antibody-mediated neutralization of animal viruses
Klasse, P. J., & Sattentau, Q. J. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-9-2091 · Cited by 287
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 287
Zwick, M. B., Jensen, R., Church, S., Wang, M., Stiegler, G., Kunert, R., Katinger, H., & Burton, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1252-1261.2005 · Cited by 278
The antiviral activity of antibodies in vitro and in vivo
Parren, P. W. H. I., & Burton, D. R. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)77018-6 · Cited by 261
Prabakaran, P., Gan, J., Feng, Y., Zhu, Z., Choudhry, V., Xiao, X., Ji, X., & Dimitrov, D. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600697200 · Cited by 238
Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
Oswald, W. B., Geisbert, T. W., Davis, K. J., Geisbert, J. B., Sullivan, N. J., Jahrling, P. B., Parren, P. W. H. I., & Burton, D. R. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030009 · Cited by 230
Biologic therapies in rheumatology: lessons learned, future directions
Strand, V., Kimberly, R., & Isaacs, J. D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2196 · Cited by 216
Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
Simmons, C. P., Bernasconi, N. L., Suguitan, A. L., Mills, K., Ward, J. M., Chau, N. V. V., Hien, T. T., Sallusto, F., Ha, D. Q., Farrar, J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040178 · Cited by 208
Mechanism of Membrane Fusion by Viral Envelope Proteins
Harrison, S. C. (2005) · Advances in Virus Research · doi:10.1016/s0065-3527(05)64007-9 · Cited by 199
Long‐term neurological and functional outcome in Nipah virus infection
Sejvar, J. J., Hossain, J., Saha, S. K., Gurley, E. S., Banu, S., Hamadani, J. D., Faiz, M. A., Siddiqui, F. M., Mohammad, Q. D., Mollah, A. H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21178 · Cited by 199
Webster, R. G., & Laver, W. G. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.1.49 · Cited by 194
Kuritzkes, D. R., Jacobson, J., Powderly, W. G., Godofsky, E., DeJesus, E., Haas, F., Reimann, K. A., Larson, J. L., Yarbough, P. O., Curt, V., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380802 · Cited by 194
Engle, M. J., & Diamond, M. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.12941-12949.2003 · Cited by 180
Isolation of anti-CD22 Fv with high affinity by Fv display on human cells
Ho, M., Nagata, S., & Pastan, I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603653103 · Cited by 179
Epitope Mapping of Flavivirus Glycoproteins
Heinz, F. X. (1986) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60263-8 · Cited by 176
Mehlhop, E., & Diamond, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052388 · Cited by 175
Potent Neutralization of Hendra and Nipah Viruses by Human Monoclonal Antibodies
Zhu, Z., Dimitrov, A. S., Bossart, K. N., Crameri, G., Bishop, K. A., Choudhry, V., Mungall, B. A., Feng, Y.-R., Choudhary, A., Zhang, M.-Y., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.891-899.2006 · Cited by 167
Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Papaneri, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Thijsse, S., Backus, H. H. J., de Kruif, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9062-9068.2005 · Cited by 166
Ebola Hemorrhagic Fever and Pregnancy
Mupapa, K., Mukundu, W., Bwaka, M. A., Kipasa, M., De Roo, A., Kuvula, K., Kibadi, K., Massamba, M., Ndaberey, D., Colebunders, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/514289 · Cited by 165
Generation of Neutralizing Human Monoclonal Antibodies against Parvovirus B19 Proteins
Gigler, A., Dorsch, S., Hemauer, A., Williams, C., Kim, S., Young, N. S., Zolla-Pazner, S., Wolf, H., Gorny, M. K., & Modrow, S. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1974-1979.1999 · Cited by 163
Understanding and making use of human memory B cells
Lanzavecchia, A., Bernasconi, N., Traggiai, E., Ruprecht, C. R., Corti, D., & Sallusto, F. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00403.x · Cited by 162
Sui, J., Li, W., Roberts, A., Matthews, L. J., Murakami, A., Vogel, L., Wong, S. K., Subbarao, K., Farzan, M., & Marasco, W. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5900-5906.2005 · Cited by 159
Self-citationvan den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1635-1644.2005 · Cited by 159
Greenough, T. C., Babcock, G. J., Roberts, A., Hernandez, H. J., Thomas, Jr., Coccia, J. A., Graziano, R. F., Srinivasan, M., Lowy, I., Finberg, R. W., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/427242 · Cited by 158
Ring Vaccination and Smallpox Control
Kretzschmar, M., van den Hof, S., Wallinga, J., & van Wijngaarden, J. (2004) · Emerging infectious diseases · doi:10.3201/eid1005.030419 · Cited by 147
Treatment of severe acute respiratory syndrome with convalescent plasma.
Wong, V. W., Dai, D., Wu, A. K. L., & Sung, J. J. �. (2003) · PubMed · Cited by 142
Gould, L. H., Sui, J., Foellmer, H. G., Oliphant, T., Wang, T., Ledizet, M., Murakami, A., Noonan, K. M., Lambeth, C., Kar, K., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14606-14613.2005 · Cited by 125
Self-citationGoudsmit, J., Marissen, W. E., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Papaneri, A. B., de Kruif, J., Dietzschold, B., Bakker, A. B. H., & Rupprecht, C. E. (2006) · The Journal of Infectious Diseases · doi:10.1086/500470 · Cited by 121
Plant biopharming of monoclonal antibodies
Ko, K., & Koprowski, H. (2005) · Virus Research · doi:10.1016/j.virusres.2005.03.016 · Cited by 115
Chen, Z., Earl, P. L., Americo, J. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510598103 · Cited by 112
Hanson, B. J., Boon, A. C. M., Lim, A. P., Webb, A., Ooi, E. E., & Webby, R. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-126 · Cited by 110
Armbruster, C., Stiegler, G. M., Vcelar, B. A., Jäger, W. R., Köller, U., Jilch, R., Ammann, C. G., Pruenster, M., Stoiber, H., & Katinger, H. W. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh428 · Cited by 107
Mejías, A., Chávez‐Bueno, S., Ríos, A. M., Fonseca-Aten, M., Raynor, B., Peromingo, E., Soni, P., Olsen, K. D., Kiener, P. A., Gomez-Lahoz, A. M., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4700-4707.2005 · Cited by 107
Neutralization of animal virus infectivity by antibody
Reading, S. A., & Dimmock, N. J. (2007) · Archives of Virology · doi:10.1007/s00705-006-0923-8 · Cited by 105
A Model for Neutralization of Viruses Based on Antibody Coating of the Virion Surface
Burton, D. R., Saphire, E. O., & Parren, P. W. H. I. (2001) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05783-4_7 · Cited by 104
Modeling Control Strategies of Respiratory Pathogens
Pourbohloul, B., Ancel, L. W., Skowronski, D. M., Krajden, M., Patrick, D. M., & Brunham, R. C. (2005) · Emerging infectious diseases · doi:10.3201/eid1108.040449 · Cited by 104
Klasse, P. J. (2007) · Virology · doi:10.1016/j.virol.2007.06.044 · Cited by 103
Roberts, A., Thomas, W. D., Guarner, J., Lamirande, E. W., Babcock, G. J., Greenough, T. C., Vogel, L., Hayes, N., Sullivan, J. L., Zaki, S. R., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500143 · Cited by 103
Sloan, S. E., Hanlon, C. A., Weldon, W. C., Niezgoda, M., Blanton, J. D., Self, J., Rowley, K. J., Mandell, R. B., Babcock, G. J., Thomas, W. D., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.12.031 · Cited by 102
SDR grafting—a new approach to antibody humanization
Kashmiri, S. V. S., Pascalis, R. D., Gonzales, N. R., & Schlom, J. (2005) · Methods · doi:10.1016/j.ymeth.2005.01.003 · Cited by 99
Sugar Determines Antibody Activity
Burton, D. R., & Dwek, R. A. (2006) · Science · doi:10.1126/science.1131712 · Cited by 92
A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis
de Kruif, J., Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Throsby, M., Rupprecht, C. E., & Goudsmit, J. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.061705.145053 · Cited by 91
Vittecoq, D., Chevret, S., Morand‐Joubert, L., Heshmati, F., Audat, F., Bary, M., Dusautoir, T., Bismuth, A., Viard, J., & Barré‐Sinoussi, F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1195 · Cited by 90
Sivakumar, G. (2006) · Biotechnology Journal · doi:10.1002/biot.200600117 · Cited by 84
Use of Intravenous Immunoglobulins for Prophylaxis or Treatment of Infectious Diseases
Hemming, V. G. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.5.859-863.2001 · Cited by 77
Chen, Z., Earl, P. L., Americo, J. L., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00906-07 · Cited by 73
Coughlin, M., Lou, G., Martinez, O., Masterman, S. K., Olsen, O. A., Moksa, A. A., Farzan, M., Babcook, J. S., & Prabhakar, B. S. (2007) · Virology · doi:10.1016/j.virol.2006.09.029 · Cited by 70
Champion, J. M., Kean, R. B., Rupprecht, C. E., Notkins, A. L., Koprowski, H., Dietzschold, B., & Hooper, D. C. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00223-9 · Cited by 69
Profiles of antibody-dependent enhancement of dengue virus type 2 infection
Morens, D. M., Halstead, S. B., & Marchette, N. J. (1987) · Microbial Pathogenesis · doi:10.1016/0882-4010(87)90056-8 · Cited by 64
Human recombinant neutralizing antibodies against hantaan virus G2 protein
Koch, J., Liang, M., Queitsch, I., Kraus, A., & Bautz, E. K. F. (2003) · Virology · doi:10.1016/s0042-6822(02)00094-6 · Cited by 63
Passive Immunotherapy in the Treatment of Advanced Human Immunodeficiency Virus Infection
Jacobson, J. M., Colman, N., Ostrow, N. A., Simson, R. W., Tomesch, D., Marlin, L., Rao, M., Mills, J. L., Clemens, J. D., & Prince, A. M. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.2.298 · Cited by 61
SARS: a case study in emerging infections.
Mclean, A., May, R. M., Pattison, J. A., & Weiss, R. (2005) · Cited by 54
Wyde, P. R., Moore, D. K., Hepburn, T. W., Silverman, C., Porter, T. G., Gross, M. S., Taylor, G., Demuth, S. G., & Dillon, S. B. (1995) · Pediatric Research · doi:10.1203/00006450-199510000-00012 · Cited by 44
Imai, M., Sugimoto, K., Okazaki, K., & Kida, H. (1998) · Virus Research · doi:10.1016/s0168-1702(97)00143-3 · Cited by 42
Isolation of Human Monoclonal Antibodies That Neutralize Human Rotavirus
Higo‐Moriguchi, K., Akahori, Y., Iba, Y., Kurosawa, Y., & Taniguchi, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3325-3332.2004 · Cited by 40
McLean, A. R., May, R. M., Pattison, J., & Weiss, R. A. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198568193.001.0001 · Cited by 40
Bregenholt, S., Jensen, A. D., Lantto, J., Hyldig, S. M. W., & Haurum, J. S. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777442173 · Cited by 39
Hadlock, K. G., Rowe, J., Perkins, S., Bradshaw, P. A., Song, G., Cheng, C.-M., Yang, J., Gascon, R. L., Halmos, J., Rehman, S. M., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5828-5840.1997 · Cited by 36
Guay, L. A., Musoke, P., Hom, D. L., Nakabiito, C., Bagenda, D. S., Fletcher, C. V., Marum, L. H., Fowler, M. G., Falksveden, L., Wahrén, B., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00011 · Cited by 35
A neutralizing recombinant human antibody Fab fragment against Puumala hantavirus
Nicacio, C. D. C., Lundkvist, �., Sjölander, K. B., Plyusnin, A., Salonen, E., & Bj�rling, E. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200004)60:4<446::aid-jmv13>3.0.co;2-v · Cited by 32
Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display
Kim, S. J., Jang, M. H., Stapleton, J. T., Yoon, S. O., Kim, K., Jeon, E., & Hong, H. J. (2003) · Virology · doi:10.1016/j.virol.2003.10.014 · Cited by 29
Farzaneh, L., Kasahara, N., & Farzaneh, F. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0189-8 · Cited by 22
Burton, D. R., & Wilson, I. A. (2007) · Science · doi:10.1126/science.1148905 · Cited by 22
Antibodies to West Nile Virus: A Double-Edged Sword
Klasse, P. J., & Burton, D. R. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.04.001 · Cited by 21
Tempest, P. R., White, P., Buttle, M., Carr, F. J., & Harris, W. J. (1995) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(95)93516-z · Cited by 20
Kim, S., & Park, S. (2002) · Hybridoma and Hybridomics · doi:10.1089/153685902761022742 · Cited by 18
Cited by
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L.-M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1566 · Cited by 1,130
Self-citationBeltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 570
(2020) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-200220-0773 · Cited by 486
Metadata
- Authors
- Marasco, W. A., & Sui, J.
- Venue
- Nature Biotechnology
- Published
- 2007-12
- Volume
- 25
- Issue
- 12
- Pages
- 1421-1434
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2000984427
- Cited by
- 284
- References
- 128
- FWCI
- 10.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.